Invokana Feet and Toes Amputation Lawsuit

Invokana Feet and Toes Amputation Lawsuit. Johnson & Johnson the world’s largest pharmaceutical and medical device maker and it’s Janssen subsidiary are under fire over serious allegations that the companies failed to warn about severe side effects from its blockbuster line of new diabetic drugs.

Case in point, according to Thomas Layton in his filed product liability lawsuit, claimed that the amputation side effects of Invokana caused him to lose a toe and some bones in his left foot. Layton from Texas developed a severe diabetic ulcer after taking the medication.

Layton alleges that the amputated toe complication has left him with reduced mobility and caused permanent disability. Layton took Invokana in May 2015, for the treatment of his diabetes. In October 2015, he developed a severe diabetic ulcer of the foot, requiring that the fifth toe to be amputated and he had to undergo further disfiguring foot surgery in August 2016.

Invokana Feet and Toes Amputation Lawsuit

The allegations at the heart of many similar product liability and personal injury lawsuits are that the companies failed to provide adequate warnings about the potential side effects of Invokana and Invokamet.

What is Invokana?

Invokana also known as canagliflozin was approved in 2013, as the first member of a new class of diabetes drugs, known as sodium-glucose cotransporter 2 (SGLT2) inhibitors.

SGLT2 inhibitors act in a unique way by excreting or releasing more glucose or sugar into the urine. Other SGLT2 inhibitors include Invokamet, Jardiance, Farxiga, and Xigduo to name a few.

Over the last few years, many diabetic patients have switched to Invokana, from other diabetic medications such as Avandia (linked to cardiovascular side effects) and Actos (linked to bladder cancer).

Now severe Invokana side effects have been discovered including Invokana amputation risks, diabetic ketoacidosis, kidney failure, heart attacks and other catastrophic injuries.

FDA Warns about Invokana Amputation Risk

Based on new data from two large clinical trials, the FDA in May 2017 concluded that the type 2 diabetes medicines Invokana, Invokamet, Invokamet XR caused an increased risk of leg and foot amputations.

The FDA is requiring new warnings, including their most prominent Boxed Warning, to be added to the Invokana drug labels to describe this risk.

As patients become aware of the amputee side effects, injured patients are filing product liability lawsuits that claim that Invokana directly caused the amputation of their leg, foot or toes.

FDA Invokana Diabetic Ketoacidosis Warnings

In December 2015, the FDA required Johnson & Johnson to add new diabetic ketoacidosis warnings to Invokana, highlighting that the medication significantly increases the risk of this potentially deadly condition.

Patients were advised by the FDA to stop taking Invokana and seek medical attention immediately if they have any symptoms of ketoacidosis, a condition when the body produces high levels of blood acids called ketones.

In June 2016, the FDA required additional label warnings about the link between Invokana and kidney risks, highlighting that the medication may increase the risk of acute kidney injury.

Invokana Amputation Litigation

Since December 2016, all federally-filed Invokana Diabetes Amputee Lawsuits have been consolidated as part of the federal Invokana multidistrict litigation (MDL), which is centralized before U.S. District Judge Brian Martinotti in the District of New Jersey to coordinate discovery and pretrial proceedings.

In order to qualify for an Invokana or Invokamet amputation lawsuit settlement, a patient must have taken Invokana or Invokamet and developed serious amputation side effects involving toes, feet or leg amputations.

If you or someone you know succumbed to an Invokana Ketoacidosis, leg, foot, toes amputations or kidney failure from taking Invokana for the treatment of their type 2 diabetes, please call us for further information at 888-210-9693. Dr. Shezad Malik Law Firm is investigating Invokana Ketoacidosis, leg amputations or kidney failure from taking Invokana for the treatment of their type 2 diabetes.